Phong Phu Pharmaceutical JSC (HNX:PPP)
Vietnam
· Delayed Price · Currency is VND 21,300
0.00 (0.00%)
At close: May 13, 2025
HNX:PPP Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 141,693 | 137,548 | 152,172 | 150,575 | 133,289 | 116,257 | Upgrade
|
| Revenue Growth (YoY) | -2.94% | -9.61% | 1.06% | 12.97% | 14.65% | -23.28% | Upgrade
|
| Cost of Revenue | 92,828 | 91,144 | 103,016 | 99,285 | 88,053 | 80,245 | Upgrade
|
| Gross Profit | 48,865 | 46,404 | 49,156 | 51,290 | 45,237 | 36,012 | Upgrade
|
| Selling, General & Admin | 26,169 | 26,149 | 26,046 | 26,096 | 25,543 | 23,330 | Upgrade
|
| Operating Expenses | 26,169 | 26,149 | 26,046 | 26,096 | 25,543 | 23,330 | Upgrade
|
| Operating Income | 22,696 | 20,255 | 23,110 | 25,194 | 19,693 | 12,682 | Upgrade
|
| Interest Expense | - | - | - | -45.36 | -434.42 | -1,649 | Upgrade
|
| Interest & Investment Income | 1,350 | 1,390 | 1,327 | 561.01 | 109.53 | 187.27 | Upgrade
|
| Currency Exchange Gain (Loss) | -2.9 | -0.96 | -1.46 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 135.85 | 143.82 | 150.99 | 93.21 | 77.97 | 332.1 | Upgrade
|
| EBT Excluding Unusual Items | 24,179 | 21,788 | 24,587 | 25,802 | 19,446 | 11,552 | Upgrade
|
| Gain (Loss) on Sale of Assets | 22.35 | 22.35 | 0.94 | - | - | - | Upgrade
|
| Pretax Income | 24,201 | 21,810 | 24,588 | 25,802 | 19,446 | 11,552 | Upgrade
|
| Income Tax Expense | 4,929 | 4,451 | 4,486 | 5,191 | 2,553 | 1,737 | Upgrade
|
| Net Income | 19,272 | 17,359 | 20,102 | 20,611 | 16,893 | 9,815 | Upgrade
|
| Preferred Dividends & Other Adjustments | 1,812 | 1,812 | 1,964 | - | - | - | Upgrade
|
| Net Income to Common | 17,460 | 15,548 | 18,138 | 20,611 | 16,893 | 9,815 | Upgrade
|
| Net Income Growth | 7.27% | -13.64% | -2.47% | 22.01% | 72.11% | -19.63% | Upgrade
|
| Shares Outstanding (Basic) | 9 | 9 | 9 | 10 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 9 | 9 | 10 | 10 | 10 | Upgrade
|
| Shares Change (YoY) | -0.84% | - | -9.83% | -0.34% | -0.72% | 5.58% | Upgrade
|
| EPS (Basic) | 1988.41 | 1766.77 | 2061.13 | 2112.00 | 1725.00 | 995.00 | Upgrade
|
| EPS (Diluted) | 1988.41 | 1766.77 | 2061.13 | 2112.00 | 1725.00 | 995.00 | Upgrade
|
| EPS Growth | 10.05% | -14.28% | -2.41% | 22.43% | 73.37% | -23.87% | Upgrade
|
| Free Cash Flow | 19,023 | 16,787 | 17,428 | 20,117 | 18,129 | 9,045 | Upgrade
|
| Free Cash Flow Per Share | 2166.42 | 1907.56 | 1980.47 | 2061.38 | 1851.27 | 916.90 | Upgrade
|
| Dividend Per Share | 1500.000 | 1500.000 | 1200.000 | 1400.000 | - | - | Upgrade
|
| Dividend Growth | 25.00% | 25.00% | -14.29% | - | - | - | Upgrade
|
| Gross Margin | 34.49% | 33.74% | 32.30% | 34.06% | 33.94% | 30.98% | Upgrade
|
| Operating Margin | 16.02% | 14.73% | 15.19% | 16.73% | 14.77% | 10.91% | Upgrade
|
| Profit Margin | 12.32% | 11.30% | 11.92% | 13.69% | 12.67% | 8.44% | Upgrade
|
| Free Cash Flow Margin | 13.43% | 12.20% | 11.45% | 13.36% | 13.60% | 7.78% | Upgrade
|
| EBITDA | 26,794 | 24,368 | 27,926 | 31,419 | 25,871 | 18,878 | Upgrade
|
| EBITDA Margin | 18.91% | 17.72% | 18.35% | 20.87% | 19.41% | 16.24% | Upgrade
|
| D&A For EBITDA | 4,098 | 4,112 | 4,816 | 6,225 | 6,178 | 6,196 | Upgrade
|
| EBIT | 22,696 | 20,255 | 23,110 | 25,194 | 19,693 | 12,682 | Upgrade
|
| EBIT Margin | 16.02% | 14.73% | 15.19% | 16.73% | 14.77% | 10.91% | Upgrade
|
| Effective Tax Rate | 20.37% | 20.41% | 18.25% | 20.12% | 13.13% | 15.04% | Upgrade
|
| Revenue as Reported | 141,693 | 137,548 | 152,172 | 150,575 | 133,289 | 116,257 | Upgrade
|
| Advertising Expenses | - | 490.39 | 285.73 | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.